UBS Maintains Buy on Option Care Health, Lowers Price Target to $39

Benzinga Newsdesk www.benzinga.com Negative 67.9%

Neg 67.9% Neu 0% Pos 0%

UBS analyst A.J. Rice maintains Option Care Health (NASDAQ:OPCH) with a Buy and lowers the price target from $45 to $39.